Voyager Therapeutics (VYGR) Price to FCF (2015 - 2026)

Voyager Therapeutics has disclosed Price to FCF across 12 years of filings, most recently posting 8.24 for Q2 2026.

• In Q2 2026, Price to FCF fell 64.15% year-over-year to 8.24; the TTM figure through Jun 2026 stood at 1.76 (down 18.47% YoY), while the FY2025 annual figure was 1.72, up 89.57% from the prior year.
• Price to FCF came in at 8.24 for Q2 2026 at Voyager Therapeutics, down from 6.96 in the prior quarter.
• In the past five years, Price to FCF ranged from a high of 8.93 in Q1 2024 to a low of 245.01 in Q2 2023.
• Average Price to FCF over 5 years is 21.41, with a median of 9.8 recorded in 2024.
• Year-over-year, Price to FCF slumped 2007.07% in 2023 and soared 228.15% in 2024.
• Over 5 years, Price to FCF stood at 17.88 in 2022, then increased by 15.18% to 15.16 in 2023, then plunged by 39.39% to 21.13 in 2024, then soared by 64.45% to 7.51 in 2025, then fell by 9.62% to 8.24 in 2026.
• Per Business Quant data, the three most recent Price to FCF figures were 8.24 in Q2 2026, 6.96 in Q1 2026, and 7.51 in Q4 2025.